title: Cereblon expression in multiple myeloma: not ready for prime time - response to Lodé et al.
authors.affiliation: Department of Internal Medicine I, Centre for Oncology and Haematology, Wilhelminenspital, Vienna, Austria.
authors.forename: Niklas
authors.initials: N
authors.lastname: Zojer
authors.forename: Daniel
authors.initials: D
authors.lastname: Heintel
authors.forename: Antonio
authors.initials: A
authors.lastname: Palumbo
authors.forename: Heinz
authors.initials: H
authors.lastname: Ludwig
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000096:biosynthesis*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000378:metabolism*; D010447:Peptide Hydrolases / Q000096:biosynthesis*
chemical_list: D014408:Biomarkers, Tumor; D010447:Peptide Hydrolases
keywords: bone-marrow microenvironment; cereblon; immunomodulatory drugs; therapy resistance